[HTML][HTML] Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
…, N Ruperto, S Goodman, A Reiff, L Jung… - … England Journal of …, 2008 - Mass Medical Soc
Background Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF …
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF …
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
…, M Fischbach, J Orozco, PJ Hashkes, C Hom, L Jung… - The Lancet, 2008 - thelancet.com
Background Some children with juvenile idiopathic arthritis either do not respond, or are
intolerant to, treatment with disease-modifying antirheumatic drugs, including anti-tumour …
intolerant to, treatment with disease-modifying antirheumatic drugs, including anti-tumour …
[HTML][HTML] Leflunomide or methotrexate for juvenile rheumatoid arthritis
E Silverman, R Mouy, L Spiegel, LK Jung… - New England journal …, 2005 - Mass Medical Soc
Background We compared the safety and efficacy of leflunomide with that of methotrexate in
the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized, …
the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized, …
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
…, AO Hersh, R Hollister, O Jones, L Jung… - Arthritis care & …, 2012 - Wiley Online Library
Objective To formulate consensus treatment plans (CTPs) for induction therapy of newly
diagnosed proliferative lupus nephritis (LN) in juvenile systemic lupus erythematosus (SLE). …
diagnosed proliferative lupus nephritis (LN) in juvenile systemic lupus erythematosus (SLE). …
[HTML][HTML] Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
…, L Zou, J Wu, L Guo, L Teng, R Zheng, LKL Jung… - Pediatric …, 2019 - Springer
Background As an acute febrile and inflammatory disease, Kawasaki disease (KD) could
develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis …
develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis …
Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …
…, E Cassidy, K Torok, M Becker, LK Jung… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …
demographic characteristics, presenting clinical features, and initial treatments in …
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima‐media thickness in the Atherosclerosis Prevention in …
…, GC Higgins, HI Brunner, L Jung… - Arthritis & …, 2009 - Wiley Online Library
Objective To evaluate risk factors for subclinical atherosclerosis in a population of patients
with pediatric systemic lupus erythematosus (SLE). Methods In a prospective multicenter study…
with pediatric systemic lupus erythematosus (SLE). Methods In a prospective multicenter study…
Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB1* 07: 01 and Severe Myositis in Juvenile Myositis Patients
…, CR Johnson, OY Jones, LK Jung… - Arthritis care & …, 2017 - Wiley Online Library
Objective Autoantibodies recognizing 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR)
are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing …
are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing …
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
…, SJ Hwang, HS Kuehn, H Kim, L Jung… - Brain, 2019 - academic.oup.com
Sir, The recent article by Ladislau et al. on the pathogenicity of type I interferon (IFN) and the
effect of type I IFN pathway blockade in vitro was received with great interest. Increasing …
effect of type I IFN pathway blockade in vitro was received with great interest. Increasing …
Development of a novel renal activity index of lupus nephritis in children and young adults
Objective Noninvasive estimation of the degree of inflammation seen on kidney biopsy with
lupus nephritis (LN) remains difficult. The objective of this study was to develop a Renal …
lupus nephritis (LN) remains difficult. The objective of this study was to develop a Renal …